Back to Screener

Healthcare

Cyteir Therapeutics, Inc.(CYT)

Live Price

Offline

$3.02

-2.27% today

1Y Change

Window

No data

Market Cap
$108.71M
Revenue Growth
0.0%
EPS Growth
-5.9%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Cyteir Therapeutics, Inc. (CYT) is a Healthcare stock with a market cap of $108.71M. The stock last traded around $3.02. Baseline metrics include revenue growth of 0.0%, EPS growth of -5.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -5.9%, free cash flow -15.1% with operating margin 0.0% and ROIC -32.4%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CYT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

0.0% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report came in below the EPS bar

2024 was reported on Mar 28, 2024 with an EPS surprise of -25.0%.

The operating picture looks softer than before

Revenue is at 0.0% and EPS is at -5.9%, with operating margin around 0.0%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

CYT

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

CYT Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CYT and SPY.

Calendar-year return history is still loading or unavailable.
CY

Company Overview

Cyteir Therapeutics, Inc.

Last Updated
May 11, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
EV/EBITDA
0.8
Price/Sales
Price/Book
0.7

Growth

Revenue
0.0%
EPS
-5.9%
Free Cash Flow
-15.1%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-26.4%
ROIC
-32.4%

Balance Sheet

Debt/Equity
0.01
Current Ratio
28.07

Earnings Reports

📅 Last reportedMar 28, 2024
PeriodB/MEPSEPS ΔRevenueRev Δ
Mar 28, 24
-0.25
Est -0.20
-25.0%
Est
Nov 6, 23
-0.10
Est
Est
Aug 7, 23
-0.24
Est -0.32
+25.0%
Est
May 10, 23
-0.35
Est -0.27
-29.6%
Est
Mar 23, 23
-0.25
Est -0.34
+26.5%
Est
Nov 7, 22
-0.31
Est -0.41
+24.4%
Est
Aug 8, 22
-0.34
Est -0.44
+22.7%
Est
May 5, 22
-0.40
Est -0.39
-2.6%
Est
Mar 16, 22
-0.34
Est -0.39
+12.8%
Est
Nov 12, 21
-0.33
Est -0.36
+8.3%
Est
Aug 9, 21
-4.83
Est -1.46
-230.8%
Est
Mar 31, 21
-0.21
Est
Est
Dec 31, 20
-0.22
Est
Est
Sep 30, 20
-0.21
Est
Est
Jun 30, 20
-0.19
Est
Est
Mar 31, 20
-0.25
Est
Est

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.